Qi Xue
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lung Cancer Diagnosis and Treatment 59
- Lung Cancer Treatments and Mutations 48
- Gastric Cancer Management and Outcomes 27
- Oncology 75
- Cancer Immunotherapy and Biomarkers 28
- Lung Cancer Research Studies 20
- Co-authors
- Jie He (71 shared papers)Fengwei Tan (62 shared papers)Shugeng Gao (59 shared papers)Shugeng Gao (46 shared papers)Wei Guo (30 shared papers)Yousheng Mao (50 shared papers)Yushun Gao (44 shared papers)Yibo Gao (20 shared papers)
- Journals
- Translational Lung Cancer Research (6 papers)Frontiers in Immunology (5 papers)Journal of Clinical Oncology (5 papers)BMC Cancer (4 papers)Annals of Surgical Oncology (4 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Qi Xue
171 papers receiving 3.0k citations
Qi Xue's Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 818
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 1.3k
- Molecular Biology 1.1k
- Surgery 651
Countries citing papers authored by Qi Xue
This map shows the geographic impact of Qi Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Xue more than expected).
Fields of papers citing papers by Qi Xue
This network shows the impact of papers produced by Qi Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Xue. The network helps show where Qi Xue may publish in the future.
Co-authors
The 25 scholars most cited alongside Qi Xue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 186 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 161 | |
| 2 | Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis Hit paper breakdown → | 2021 | 160 |
| 3 | 2021 | 150 | |
| 4 | 2022 | 99 | |
| 5 | 2020 | 90 | |
| 6 | 2020 | 76 | |
| 7 | 2021 | 70 | |
| 8 | 2019 | 65 | |
| 9 | 2020 | 63 | |
| 10 | 2020 | 50 | |
| 11 | 2016 | 47 | |
| 12 | 2013 | 46 | |
| 13 | 2022 | 46 | |
| 14 | 2022 | 44 | |
| 15 | 2013 | 41 | |
| 16 | 2015 | 41 | |
| 17 | 2019 | 39 | |
| 18 | 2007 | 36 | |
| 19 | 2023 | 35 | |
| 20 | 2022 | 33 |
About Qi Xue
Qi Xue is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Cancer Research, having authored 186 papers that have together received 3.0k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (59 papers), Lung Cancer Treatments and Mutations (48 papers), Esophageal Cancer Research and Treatment (30 papers), Cancer Immunotherapy and Biomarkers (28 papers), Gastric Cancer Management and Outcomes (27 papers), Lung Cancer Research Studies (20 papers), RNA modifications and cancer (18 papers) and Cancer-related molecular mechanisms research (16 papers). The work is most often cited by research in Cancer Research (818 citations), Oncology (1.2k citations), Pulmonary and Respiratory Medicine (1.3k citations), Molecular Biology (1.1k citations) and Surgery (651 citations). Qi Xue has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jie He, Fengwei Tan, Shugeng Gao, Shugeng Gao, Wei Guo, Yousheng Mao, Yushun Gao, Yibo Gao, Guochao Zhang and Juwei Mu. Their work appears in journals such as Translational Lung Cancer Research, Frontiers in Immunology, Journal of Clinical Oncology, BMC Cancer and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.